Operating
Deferred Taxes
Bristol-Myers Squibb Deferred Taxes increased by 141.1% to $161.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 27.8%, from $223.00M to $161.00M. Over 4 years (FY 2021 to FY 2025), Deferred Taxes shows an upward trend with a -8.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Significant changes can indicate shifts in tax strategy, capital investment timing, or changes in accounting estimates.
Detailed definition
Deferred income taxes represent the temporary differences between the tax expense reported on the income statement and t...
Peer comparison
Standard line item for all large corporations subject to complex tax jurisdictions.
Metric ID:
deferred_income_taxesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$163.00M | -$32.00M | -$1.27B | -$687.00M | -$782.00M | -$645.00M | -$624.00M | -$548.00M | -$1.09B | -$327.00M | -$1.33B | -$711.00M | -$331.00M | -$256.00M | -$791.00M | $223.00M | -$437.00M | -$359.00M | -$392.00M | $161.00M |
| QoQ Change | — | +80.4% | <-999% | +45.7% | -13.8% | +17.5% | +3.3% | +12.2% | -98.2% | +69.9% | -305.8% | +46.4% | +53.4% | +22.7% | -209.0% | +128.2% | -296.0% | +17.8% | -9.2% | +141.1% |
| YoY Change | — | — | — | — | -379.8% | <-999% | +50.7% | +20.2% | -38.9% | +49.3% | -112.7% | -29.7% | +69.5% | +21.7% | +40.4% | +131.4% | -32.0% | -40.2% | +50.4% | -27.8% |
Range-$1.33B – $223.00M
CAGR-0.3%
Avg YoY Growth-133.9%
Median YoY Growth-3.8%
Deferred Taxes at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's deferred taxes?
- Bristol-Myers Squibb (BMY) reported deferred taxes of $161.00M in Q1 2026.
- How has Bristol-Myers Squibb's deferred taxes changed year-over-year?
- Bristol-Myers Squibb's deferred taxes decreased by 27.8% year-over-year, from $223.00M to $161.00M.
- What is the long-term trend for Bristol-Myers Squibb's deferred taxes?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's deferred taxes has grown at a -8.8% compound annual growth rate (CAGR), from -$1.39B to -$965.00M.
- What does deferred taxes mean?
- The difference between tax reported on financial statements and actual taxes owed to the government.